Vertical transmission of hepatitis C virus and follow-up of newborns from infected mothers

F. Polatti, F. Viazzo, R. Colleoni, C. Belloni, F. Zara

Research output: Contribution to journalArticle

Abstract

Background. Aim of the study is to analyze the rate of vertical transmission of HCV and the time of clearance of maternal antibodies in non-infected babies serum. Methods. We have studied 36 babies born to HCV-positive and HIV-negative pregnant women at the University of Pavia. All mothers underwent blood tests to evaluate the presence of anti-HCV antibodies and viral RNA during pregnancy and after delivery. All babies under-went several tests at different times to evaluate the presence of viral RNA and the clearance of maternal antibodies. Results. All babies proved HCV-Ab positive at birth, but only one case (2.7%) proved infected at PCR analysis. Different patterns of HCV-Ab clearance were noted in the 35 non-infected babies. Of 24 babies from HCV-RNA-positive mothers, HCV-Ab reached zero in 24 months while in 11 babies from HCV-RNA-negative mothers, the antibodies disappeared at 12 months. A statistical difference was noted between the two groups of babies for the time of clearance of antibodies. Conclusions. The risk of vertical transmission in babies born to HCV-RNA negative mothers is very low, and the clearance of maternal antibodies is set within 12 months of follow-up. Mothers positive to HCV-RNA have a higher risk of transmitting the virus to their offspring and the time of clearance of antibodies in non-infected babies seems to be longer. A correct follow-up of these children must be no shorter than 24 months.

Original languageEnglish
Pages (from-to)59-62
Number of pages4
JournalMinerva Ginecologica
Volume52
Issue number3
Publication statusPublished - 2000

Fingerprint

Hepacivirus
Mothers
Newborn Infant
Antibodies
RNA
Viral RNA
Hepatitis C Antibodies
Hematologic Tests
Pregnant Women
HIV
Parturition
Viruses
Pregnancy
Polymerase Chain Reaction
Serum

Keywords

  • Disease transmission vertical
  • Hepatitis-C
  • Infections
  • Pregnancy complications
  • Virus diseases transmission

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Vertical transmission of hepatitis C virus and follow-up of newborns from infected mothers. / Polatti, F.; Viazzo, F.; Colleoni, R.; Belloni, C.; Zara, F.

In: Minerva Ginecologica, Vol. 52, No. 3, 2000, p. 59-62.

Research output: Contribution to journalArticle

Polatti, F, Viazzo, F, Colleoni, R, Belloni, C & Zara, F 2000, 'Vertical transmission of hepatitis C virus and follow-up of newborns from infected mothers', Minerva Ginecologica, vol. 52, no. 3, pp. 59-62.
Polatti, F. ; Viazzo, F. ; Colleoni, R. ; Belloni, C. ; Zara, F. / Vertical transmission of hepatitis C virus and follow-up of newborns from infected mothers. In: Minerva Ginecologica. 2000 ; Vol. 52, No. 3. pp. 59-62.
@article{38a6327b86df4e08bfd6dc40497f00d9,
title = "Vertical transmission of hepatitis C virus and follow-up of newborns from infected mothers",
abstract = "Background. Aim of the study is to analyze the rate of vertical transmission of HCV and the time of clearance of maternal antibodies in non-infected babies serum. Methods. We have studied 36 babies born to HCV-positive and HIV-negative pregnant women at the University of Pavia. All mothers underwent blood tests to evaluate the presence of anti-HCV antibodies and viral RNA during pregnancy and after delivery. All babies under-went several tests at different times to evaluate the presence of viral RNA and the clearance of maternal antibodies. Results. All babies proved HCV-Ab positive at birth, but only one case (2.7{\%}) proved infected at PCR analysis. Different patterns of HCV-Ab clearance were noted in the 35 non-infected babies. Of 24 babies from HCV-RNA-positive mothers, HCV-Ab reached zero in 24 months while in 11 babies from HCV-RNA-negative mothers, the antibodies disappeared at 12 months. A statistical difference was noted between the two groups of babies for the time of clearance of antibodies. Conclusions. The risk of vertical transmission in babies born to HCV-RNA negative mothers is very low, and the clearance of maternal antibodies is set within 12 months of follow-up. Mothers positive to HCV-RNA have a higher risk of transmitting the virus to their offspring and the time of clearance of antibodies in non-infected babies seems to be longer. A correct follow-up of these children must be no shorter than 24 months.",
keywords = "Disease transmission vertical, Hepatitis-C, Infections, Pregnancy complications, Virus diseases transmission",
author = "F. Polatti and F. Viazzo and R. Colleoni and C. Belloni and F. Zara",
year = "2000",
language = "English",
volume = "52",
pages = "59--62",
journal = "Minerva Ginecologica",
issn = "0026-4784",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Vertical transmission of hepatitis C virus and follow-up of newborns from infected mothers

AU - Polatti, F.

AU - Viazzo, F.

AU - Colleoni, R.

AU - Belloni, C.

AU - Zara, F.

PY - 2000

Y1 - 2000

N2 - Background. Aim of the study is to analyze the rate of vertical transmission of HCV and the time of clearance of maternal antibodies in non-infected babies serum. Methods. We have studied 36 babies born to HCV-positive and HIV-negative pregnant women at the University of Pavia. All mothers underwent blood tests to evaluate the presence of anti-HCV antibodies and viral RNA during pregnancy and after delivery. All babies under-went several tests at different times to evaluate the presence of viral RNA and the clearance of maternal antibodies. Results. All babies proved HCV-Ab positive at birth, but only one case (2.7%) proved infected at PCR analysis. Different patterns of HCV-Ab clearance were noted in the 35 non-infected babies. Of 24 babies from HCV-RNA-positive mothers, HCV-Ab reached zero in 24 months while in 11 babies from HCV-RNA-negative mothers, the antibodies disappeared at 12 months. A statistical difference was noted between the two groups of babies for the time of clearance of antibodies. Conclusions. The risk of vertical transmission in babies born to HCV-RNA negative mothers is very low, and the clearance of maternal antibodies is set within 12 months of follow-up. Mothers positive to HCV-RNA have a higher risk of transmitting the virus to their offspring and the time of clearance of antibodies in non-infected babies seems to be longer. A correct follow-up of these children must be no shorter than 24 months.

AB - Background. Aim of the study is to analyze the rate of vertical transmission of HCV and the time of clearance of maternal antibodies in non-infected babies serum. Methods. We have studied 36 babies born to HCV-positive and HIV-negative pregnant women at the University of Pavia. All mothers underwent blood tests to evaluate the presence of anti-HCV antibodies and viral RNA during pregnancy and after delivery. All babies under-went several tests at different times to evaluate the presence of viral RNA and the clearance of maternal antibodies. Results. All babies proved HCV-Ab positive at birth, but only one case (2.7%) proved infected at PCR analysis. Different patterns of HCV-Ab clearance were noted in the 35 non-infected babies. Of 24 babies from HCV-RNA-positive mothers, HCV-Ab reached zero in 24 months while in 11 babies from HCV-RNA-negative mothers, the antibodies disappeared at 12 months. A statistical difference was noted between the two groups of babies for the time of clearance of antibodies. Conclusions. The risk of vertical transmission in babies born to HCV-RNA negative mothers is very low, and the clearance of maternal antibodies is set within 12 months of follow-up. Mothers positive to HCV-RNA have a higher risk of transmitting the virus to their offspring and the time of clearance of antibodies in non-infected babies seems to be longer. A correct follow-up of these children must be no shorter than 24 months.

KW - Disease transmission vertical

KW - Hepatitis-C

KW - Infections

KW - Pregnancy complications

KW - Virus diseases transmission

UR - http://www.scopus.com/inward/record.url?scp=0034155115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034155115&partnerID=8YFLogxK

M3 - Article

C2 - 10905077

AN - SCOPUS:0034155115

VL - 52

SP - 59

EP - 62

JO - Minerva Ginecologica

JF - Minerva Ginecologica

SN - 0026-4784

IS - 3

ER -